3//SEC Filing
6 Dimensions Capital, L.P. 3
Accession 0001104659-19-040821
CIK 0001680581other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 7:42 PM ET
Size
4.4 KB
Accession
0001104659-19-040821
Insider Transaction Report
Form 3
6 Dimensions Capital, L.P.
10% Owner
Holdings
Series B Preferred Stocks
→ Common Shares (441,071 underlying)
Footnotes (1)
- [F1]The Series B Preferred Stock is convertible into Common Stock on 7:1 basis into the number of shares shown in column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001717958
Filing Metadata
- Form type
- 3
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 7:42 PM ET
- Size
- 4.4 KB